Published by Iain Gilbert on 21st October 2021
(Sharecast News) - Reneuron Group revealed on Thursday that non-executive director Barbara Staehelin had acquired 43,000 ordinary shares in the AIM-listed cell-based therapeutics developer.
URL: http://www.digitallook.com/dl/news/story/32209826/...